Navigation Links
42-year-old Cancer Patient Honored by British Queen for Her Fundraising Efforts

Jane Tomlinson, a doughty fighter against cancer, has been conferred the honor of CBE in the Queens Birthday honors list. The 42-year-old pediatric radiologist, hailing from Leeds in UK , was first diagnosed with breast cancer when she was only 26. Despite a mastectomy, the disease returned to haunt her a decade later, spreading to her lungs and bones. It would get you this time, she was told six years ago.

But undaunted she has carried on with her efforts to raise funds for charities fighting cancer. She has raised over 1.5m for charity through several marathons and epic bike rides. The mother of three cycled 4,200 miles across the US in nine weeks for her final fundraising challenge in 2006.

Her health proved a huge challenge during the journey from San Francisco to New York, with organizers considering abandoning the ride and admitting Jane to hospital just two days before the finish line. She completed the ride on the sixth anniversary of the day she had been given just six months to live. Mrs Tomlinson is the only person with incurable cancer to complete a full Ironman event which consists of a 4km swim, 180km bike ride and full marathon to be done inside 17 hours.

She has also completed two half Ironmans, run the London Marathon three times, the New York Marathon and three London Triathlons and is the only person to do the marathon whilst on chemotherapy. Her brother has completed two tandem bike rides with her - one from Lands End to John O' Groats and the other from Rome to Leeds. At the same time she has had four courses of chemotherapy and as a result of her drug regimes has chronic heart disease.

Among the many accolades she has achieved for her mammoth fundraising efforts she has received the BBC Sports Personality of the Year Award and a Pride of Britain Award. She has said she will no longer take part in fundraising events herself but 8,000 people have signed up to do the 'Run For All' 10k in Leed
'"/>




Page: 1 2

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
(Date:10/10/2008)...n (a) levels boost cardiovascular disease risk fo...y News) -- If you,re worried about reducing your r...at you should quit smoking, eat a healthful diet, ...eck, and make sure your cholesterol levels aren,t ...ein (a) levels are? , Well, if you don,t have ...
(Date:10/10/2008)...mpany committed to helping people address health n.../ -- In these troubling,economic times, people may... may feel that they don,t have the money to visit ...a survey by the National Association of,Insurance ... -- Twenty-two percent of Americans say that they ...
(Date:10/10/2008)...Oct. 10 /PRNewswire/ -- Do you think that the blin...d town? Attend the October,17 open house at the Vi...ion Impaired, and see how instructors there empowe...ve, fulfilling lives through non-visual,techniques...1 Azalea Avenue, is holding an open house to,celeb...
(Date:10/10/2008)...omy serving as tipping point for behavior change, ...-- More than half of,Americans (51 percent) believ...are system, but major changes are needed, accordin...urvey was released today by the,Employee Benefit R...tes,Inc., and was underwritten by the Principal Fi...
Breaking Medicine News(10 mins):Health News:Little-Known Fat Can Be a Heartbreaker 2Health News:Little-Known Fat Can Be a Heartbreaker 3Health News:Healthcare Resources Available in Difficult Times 2Health News:Healthcare Resources Available in Difficult Times 3Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3
...diabetes, and arthritis are among a variety of aut... of white blood cell, called the immune regulatory...s malfunction is when a mutation in the FOXP3 gene...In a new study published online this week in the P...
...cted on mice shows that more copper in everyday di...ducted by scientists at the University of Louisvil...esearch Center. Their studies show that giving co...ress on their over-worked hearts by preventing hea...
...cted by American Academy of Neurology finds that e...providing short-term pain relief for lower back pa...long-term pain relief. To develop the guideline, ...c studies on the topic. According to the guidelin...
...time. An extra hour to enjoy life outside. An extr.../ . What should we do when the clock jukes and ji...aves that regulate our sleep? It’s bad enough for... concept. What about kids, who will want to squeez...
Other Medicine News:Health News:Researchers Discover New Molecular Path to Fight Autoimmune Diseases 2Health News:Use Daylight-saving Change to Practice Healthy Sleep Habits 2
(Date:10/8/2008)... LYON, France, Oct. 8 /- Vical In...panded clinical data and new nonclinical data,demo... may be broadly,applicable in DNA- and protein-bas...ancer vaccines. Alain P. Rolland, Pharm.D., Ph.D.,...ent, will present the data today,Wednesday, Octob...
(Date:10/7/2008)... Study evaluates the efficacy of new device for de...issed during colonoscopy, ORLANDO, Fla., Oct. 7 /...terology Annual Scientific Meeting in Orlando (ACG..., MD presented results from a,multi-institutional ...Third,Eye(R) Retroscope(R), a new device that is d...
(Date:10/7/2008)... Study Showed Larazotide Acetate Prevented Immun...n Patients with Celiac Disease, Additional Data In...isease, ORLANDO, Fla., Oct. 7 /- Alb...two clinical studies this week at the American,Col...fic Meeting. Data from,study CLIN 1001-004, the fi...
(Date:10/7/2008)... - Data Presented Today at ACG Annual Sci...ire-FirstCall/ -- Ironwood,Pharmaceuticals, Inc. (...Inc. (NYSE: FRX ) today announced the presentatio...lotide,s safety and efficacy in 420 patients with,.... Analysis of the data,indicates that once- daily ...
Breaking Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Your belly fat could be making you hungrier 17023 1Your belly fat could be making you hungrier 17023 2GHX Introduces NuVia 28TM 29 an Artificial Intelligence based Technology That Enables a New Approach to Content Management for Healthcare Providers 17020 1GHX Introduces NuVia 28TM 29 an Artificial Intelligence based Technology That Enables a New Approach to Content Management for Healthcare Providers 17020 2GHX Introduces NuVia 28TM 29 an Artificial Intelligence based Technology That Enables a New Approach to Content Management for Healthcare Providers 17020 3The Miracle of Funding by State and Local Pension Plans 17016 1The Miracle of Funding by State and Local Pension Plans 17016 2AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its Communities 17012 1AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its Communities 17012 2AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its Communities 17012 3
...ewswire/ -- A new study,demonstrated that the acti...cg twice a day, may improve symptom relief rates i...pation (IBS-C). These,results were presented as a ...argest annual international meeting of digestive d...eiving lubiprostone were nearly,twice as likely to...
...007 - Results from phase III,clinical trials and f...t the 16th Congress of the European Academy of,Der...ghted the,efficacy and safety profile of alitretin...atients with severe refractory chronic,hand eczema...vere Chronic Hand,Eczema (CHE) refractory or unres...
Other Medicine Technology:New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 2New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 3New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 4New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 5New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 6Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5
...ell (nRBC) control for evaluating the accuracy and... analyzer in its enumeration of the nRBC parameter.... nRBC-Chex for LH is a two-level control packaged...H has a 75-day closed-vial stability and a 14-day ...
...e blood control to test for the presence of Hemogl...horesis. Sickle-Chex is compatible with Streck SIC...Sickle-Chex is packaged in a 2.5ml plastic squeeze...le volume. No pipeting is required. The product do...
...essentially eliminates premature deployment or jum...anatomically designed tapered stent for better fit...xchange catheter with 6 Fr low crossing profile an...er on catheter clearly indicates tapered location ...
... control assayed for all parameters on the Coulter...AcT diff2, MD Series and ONYX Series; Abbott CELL-...0; and Diatron Abacus and Abacus Junior. Para 12 E...six-month closed-vial stability and is available i...
Medicine Products: